CORDIS
EU research results

CORDIS

English EN
Rapid diagnosis of preeclampsia at the point-of-care

Rapid diagnosis of preeclampsia at the point-of-care

Objective

MOMM Diagnostics conceives a new generation of in-vitro diagnostic tests for early diagnosis of preeclampsia. Preeclampsia remains to this day one of the leading causes for maternal mortality. Early diagnosis is therefore vital to minimize complications and prepare adequately for birth. The startup is developing a solution using microscale solid-state sensors for electrical detection of biomarkers in blood, which would allow the detection of multiple biomarkers, using a single-use cartridge and a hand-held reader for diagnosis of the condition directly where the patients are being taken care of. Technology originating from results of the FETOPEN project RECORD-IT (Project ID: 664786) has shown promising innovation potential. MOMM Diagnostics aims to verify this potential for commercialization by assessing its competitiveness for point of care applications. The technology promises an increased signal to noise ratio at a smaller form factor and lower cost compared to commercially available technologies. The FET Innovation Launchpad will help to consolidate the intellectual property rights and develop a demonstrator to approach investors.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

MOMM DIAGNOSTICS GMBH

Address

Hochbergerstrasse 60c
4057 Basel

Switzerland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU Contribution

€ 72 000

Participants (1)

Sort alphabetically

Sort by EU Contribution

Expand all

EIDGENOSSISCHE MATERIALPRUFUNGS- UND FORSCHUNGSANSTALT

Switzerland

EU Contribution

€ 28 000

Project information

Grant agreement ID: 848551

Status

Ongoing project

  • Start date

    1 May 2019

  • End date

    30 April 2020

Funded under:

H2020-EU.1.2.1.

  • Overall budget:

    € 150 000

  • EU contribution

    € 100 000

Coordinated by:

MOMM DIAGNOSTICS GMBH

Switzerland